The Path to Cure: Using Haploidentical (haplo) Donors and High-Dose Post-Transplant Cyclophosphamide (PTCy) for Treatment-Naive and Refractory Severe Aplastic Anemia (SAA)

被引：1
|
作者：
DeZern, Amy E. [1 ]
Zahurak, Marianna [2 ]
Cooke, Kenneth R. [3 ]
Margolis, David [4 ]
Jones, Richard J. [1 ]
Brodsky, Robert A. [5 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Sidney Kimmel Comprehens Canc Ctr, Sparks, MD USA
[3] Johns Hopkins, Sidney Kimmel Comp Canc Ctr, Baltimore, MD USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[5] Johns Hopkins Univ, Dept Med, Div Hematol, Baltimore, MD USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-121900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis
    Ghiso, Anna
    Raiola, Annamaria
    Gualandi, Francesca
    Dominietto, Alida
    Varaldo, Riccardo
    van Lint, Maria Teresa
    Bregante, Stefania
    Di Grazia, Carmen
    Lamparelli, Teresa
    Luchetti, Silvia
    Geroldi, Simona
    Tedone, Elisabetta
    Bacigalupo, Andrea P.
    BLOOD, 2012, 120 (21)
  • [42] Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Herrera, Pilar
    Bermudez, Arancha
    Sampol, Antonia
    Jimenez, Santiago
    Lopez-Corral, Lucia
    Serrano, David
    Montesinos, Pau
    Pascual, Maria-Jesus
    Heras, Inmaculada
    Bento, Leyre
    Varela, Rosario
    Humala, Karem
    Zabalza, Amaya
    Laiglesia, Almudena
    Bastos-Oreiro, Mariana
    Perez-Corral, Ana
    Martinez-Laperche, Carolina
    Diez-Martin, Jose Luis
    BLOOD, 2016, 128 (22)
  • [43] Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia
    Brodsky, RA
    Sensenbrenner, LL
    Smith, BD
    Dorr, D
    Seaman, PJ
    Lee, SM
    Karp, JE
    Brodsky, I
    Jones, RJ
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (07) : 477 - 483
  • [44] Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study
    Yesilipek, M. Akif
    Uygun, Vedat
    Karasu, Gulsun
    Daloglu, Hayriye
    Dincer, Zeynep
    PEDIATRIC TRANSPLANTATION, 2016, 20 (03) : 417 - 423
  • [45] SAFETY OF T-CELL REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTATION USING FLUDARABINE, MELPAHALAN AND THIOTEPA CONDITIONING AND HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Ciurea, S. O.
    de Lima, M.
    Kebriaei, P.
    Rondon, G.
    Saliba, R.
    McMannis, J.
    Andersson, B. S.
    Khouri, I. F.
    Giralt, S.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S218 - S218
  • [46] Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study
    Uygun, Vedat
    Karasu, Gulsun
    Daloglu, Hayriye
    Ozturkmen, Seda
    Kilic, Suar Caki
    Hazar, Volkan
    Yesilipek, Akif
    PEDIATRIC TRANSPLANTATION, 2019, 23 (07)
  • [47] Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study
    Uygun, Vedat
    Karasu, Gulsun
    Ozturkmen, Seda
    Daloglu, Hayriye
    Kilic, Suar
    Hazar, Volkan
    Yesilipek, Akif
    BONE MARROW TRANSPLANTATION, 2018, 53 : 274 - 275
  • [48] Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide
    Maeda, Yoshinobu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) : 1 - 9
  • [49] OUTCOME OF HAPLOIDENTICAL PBSC TRANSPLANTATION FOR HIGH RISK APLASTIC ANEMIA WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IS SIMILAR TO MATCHED SIBLING PBSCT AND DEPENDS ON CHOICE OF DONORS: ADVERSE EFFECT OF NATURAL KILLER CELL ALLOREACTIVITY
    Jaiswal, S. Rani
    Apte, S.
    Kannan, S.
    Chakrabarti, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S121 - S121
  • [50] NON MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST GRAFT HIGH DOSE CYCLOPHOSPHAMIDE FOR REFRACTORY SAA OR AFTER FAILED UNRELATED OR CORD BLOOD TRANSPLANT
    Kulasekararaj, A.
    Potter, V.
    Clay, J.
    Mclornan, D.
    Raj, K.
    De Lavallade, H.
    Kenyon, M.
    Pagliuca, A.
    Mufti, G. J.
    Marsh, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S121 - S121
12345